GlassScriptPhysician profile
Monica L Johnson
NPI 1275509283
$1,475.44
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.77 · 2020: $247 · 2021: $331 · 2022: $350 · 2023: $142 · 2024: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $471.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $231.04 | 2020-2024 | Dupixent |
| Csl Behring | $205.46 | 2019-2022 | |
| Kaleo, INC. | $189.87 | 2020-2024 | Auvi-Q |
| Glaxosmithkline, LLC. | $151.12 | 2021-2024 | Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $122.57 | 2020-2024 | Cuvitru |
| Optinose US, INC. | $86.59 | 2019-2023 | |
| Genentech USA, INC. | $83.04 | 2022-2024 | Xolair |
| Astrazeneca Pharmaceuticals LP | $76.87 | 2020-2022 | |
| Grifols USA, LLC | $50.60 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $41.67 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.02 | 2020-2021 | |
| Alk-Abello, INC | $34.08 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $28.40 | 2024 | |
| Amgen INC. | $24.35 | 2022 | |
| Pharming Healthcare, INC. | $23.12 | 2024 | Ruconest |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $18.33 | 2022 | |
| Abbvie INC. | $15.82 | 2021 | |
| Octapharma USA, INC. | $15.00 | 2022 | |
| Philips North America LLC | $14.64 | 2021 | |
| Pfizer INC. | $14.09 | 2022 | |
| Biocryst US Sales Co., LLC | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.